IL2 and breast cancer: Proteomic analysis of CD45+ MPE cells. Cytocentrifuge slides were prepared from 12 breast cancer MPE, two peripheral blood mononuclear cell preparations (PBMC), and one activated PIT (2 conditions: IL-2/CD3/CD28/IFNγ and LPS/IFNγ).